Vol. 168, No. 3, 1990
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
BIOCHEMICAL
Pages 1184-1193
May 16, 1990
INCREASED
MITOGENIC EXPRESSING
Ian Zachary*,
RESPONSIVENESS CONSTITUTIVELY
OF SWISS 3T3 CELLS ACTIVE Gsa
Susan B. Masters and Henry R. Boume#
University of California, San Francisco, California 94143 Cancer Research Fund, Lincoln’s Inn Fields, London WC2A 3PX, UK
*Imperial Received
March
19,
1990
Abstract: Mutational replacement of glutaminewith a leucine residue in the GTP-binding domain of the a subunit of Gs (Q227L as) reduces its ability to hydrolyse GTP and causes constitutive activation of the mutant protein. Expression in Swiss 3T3 fibroblasts of Q227L as caused markedly increased basal adenylyl cyclase activity, enhanced intracellular cyclic AMP (CAMP) accumulation and increased mitogenic sensitivity in response to forskolin and the potent phosphodiesterase inhibitor Ro 20-1724. These results support a role for CAMP in the regulation of cell proliferation, and suggest that alterations in a G protein can directly modify the ability of cells to respond mitogenically to extracellular factors. 01990 Academic Press, Inc.
An increase in the intracellular a mitogenic
signal in a wide variety
in Saccharamyces intracellular forskolin
cerevisiae
CAMP
-
and inhibitors
mitogenesis
content of cyclic AMP (cAMP) can act as
in synergistic
(2). Intracellular
of cultured
(1,2).
including
E-type
of cyclic nucleotide combinations
prostaglandins, phosphodiesterases
that raise
cholera -
toxin,
stimulate
with other growth promoting
CAMP is also increased
kinase C, including
cells, as well as
In Swiss 3T3 cells, agents
growth factor (3) and vasoactive intestinal protein
mammalian
the neuropeptide
agents
in these cells by platelet-derived peptide
(4); agents which activate
bombesin
(5) and phorbol
“Address correspondence to Henry R. Bourne, University of California-San Department of Pharmacology, Box 0450, Room 51210, San Francisco, CA 94143.
esters
Francisco,
Abbreviations: Gs, the GTP-binding protein which activates adenylyl cyclase; as, the GTFbinding domain of Gs; Q227L as, as in which glutamine 227 is replaced by leucine; GTE, guanosine S&phosphate; GppNHp, guanylyl-S’knidodiphosphate; Ro 20-1724, I-(3-butoxy4-methylbenzyl)-2-imidazolidine; IBMX, I-methyl-3-isobutylxanthine; PGEl, prostaglandin EI. 0006-291X/90 $1.50 Copyright 0 1959 by Academic Press, Inc. All rights of reproduction in any form reserved.
1184
Vol.
168, No. 3, 1990
BIOCHEMICAL
(6), can also act indirectly
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
to enhance CAMP accumulation
via an unknown
mechanism. Synthesis GTP-binding
of CAMP subunit
by hormonal
of Gs that is responsible
receptors to activation subunit
is stimulated
of adenylyl
cyclase (7,8).
function
role in the intrinsic
of all G proteins
conserved glutamine activation
at position
of adenylyl
(10, 11). Mutation
Mutational
replacements constitutive
and
activation
mechanisms
domain activity
acid similarly
to the
replacement
colleagues
residue in p2lras,
to promote
of a
recently
of adenylyl
reported
relaxation
pathways
predict
of the normal
MATERIALS
stimulus.
for cellular
cyclase and increased
activating
growth control
used as a model
important
hormone-
that dominant
constitutive
effects of CAMP-elevating
mutational
Q227, are associated with
of mutant
of adenylyl
transformation
(13) that
in cells in which CAMP can act as a mitogenic
signal transduction
to
and enhances
cyclase in a subset of growth
These findings
in 01~ will cause a partial
glutamine-61,
malignant
(2). Here we report that expression
mitogenic
essential
reduces GTPase activity
ras protein
tumours.
activation
of this protein
227 by leucine (Q227L a,) causes constitutive
Swiss 3T3 cells have been extensively elucidating
analysis of the a,
mutational
of specific residues in a s, including
secreting pituitary mutations
Specifically,
of the corresponding
of the mutant
Landis
(12).
GTPase
stimulatory
cyclase as a consequence of decreased GTPase activity
almost any other amino the capacity
(9-11).
of asI the
for coupling
of Gs has defined a region in the GTP-binding
which plays a crucial
activation
system for proliferation
Q227L a, in these cells causes sensitivity
to the
agents. AND METHODS
Swiss 3T3 cells were maintained in culture and assays of DNA synthesis, adenylyl cyclase activity and CAMP accumulation were performed as described (5, 1416). Preparation of whole cell RNA and Northern blot analysis with a full-length cDNA for rat os (17) were also performed as described (5). Construction and expression of mutant as chains. Subcloning of normal rat 01~ (GRS) (17) and mutant recombinant os (10) into the retroviral expression vector pMV-7 (18) were performed as previously described (10). Q227L as was generated from pGRAS, an altered form of pGRS that lacked part of the polylinker and the 5’ noncoding region but was otherwise 1185
Vol.
BIOCHEMICAL
168, No. 3, 1990
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
identical. After passage of the vectors through packaging cell lines (19), Swiss 3T3 cells were infected and independent transformants were selected by growth in Dulbecco’s modified Eagle’s medium containing 10% fetal calf serum and G418 at a concentration of 500 pg/ml. Membrane preparation . Confluent and quiescent cultures of Swiss 3T3 cells were trypsinized and pelleted. The pellet was washed twice in 10 ml of 5 mM 4-(3-butoxy-4-methylbenzyl)-Z-imidazolidine (HEPES), pH 7.4, 2 mM MgC12, 0.2 mM phenylmethylsulphonyl fluoride and resuspended in 3 ml of the same buffer. The cell suspension was frozen and thawed 3 times and homogenized by 100 strokes in a dounce homogenizer and centrifuged for 10 min at 1000 ‘pm. The supernatant containing a crude particulate fraction was centrifuged for 30 min at maximum speed in a microcentrifuge. Membranes were resuspended and stored at -70°C in 40 mM HEPES, pH 7.4,0.15 M NaCl, 20% glycerol. Protein was determined as described (20). proteins were resolved on a Immunoblot analysis of a,. Membrane 10% SDS-polyacrylamide gel, transferred to nitrocellulose and immunoblotted with affinity-purified antiserum (4 pg/ml) directed against a peptide (DATPEPGEDPRVTRAK) located in the carboxy terminal half of as (21).
Materials. Insulin, l-methyl-3-isobutylxanthine (IBMX), forskolin, prostaglandin El (PGEi), guanosine 5’-triphosphate (GTP) and guanylyl3’imidodiphosphate (Gpp(NHlp) were obtained from Sigma Chemical Co., St. Louis, MO. Cholera toxin was supplied by List Biological Laboratories (Campbell, CA). 4-(3-butoxy-4-methylbenzyl)-2-imidazolidine (Ro 20-1724) was purchased from Biomol. Research Lab. Inc., Plymouth Meeting, PA. Radioisotopes and antigens and antibodies for the radioimmunoassay of CAMP were obtained from Amersham International (U.K.). 3H-CAMP was obtained from New England Nuclear, Boston, MA. All other materials used were of reagent grade. RESULTS AND DISCUSSION
Swiss 3T3 cells infected with wild-type
and mutant
cDNAs
encoding
the 52 kDa form of as were screened by examining
the incorporation
of 3H-
adenine
inhibitor
caused
into
approximately
CAMP.
The
phosphodiesterase
8-fold more incorporation
of radioactivity
infected with Q227L a, than in cells infected with normal cells.
Five out of 5 clones infected
CAMP
in the presence
normal
of IBMX
as or uninfected
further phenotypic
cells.
into CAMP in cells 01s or in uninfected
with Q227L as also exhibited
as compared
to clones infected
elevated with
the
Two clones of each type were selected for
analysis.
Swiss 3T3 cells infected with Q227L as exhibited adenylyl
IBMX
cyclase activity,
measured
a marked
increase in
in the presence of GTP alone (Fig. 1). In 1186
Vol.
168, No. 3, 1990
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
L n
GTP
n
GTP+PGE,
n
GP~NHP
q
GppNHp+PGE
q
Forskolln
GRS5
GUS?
Adenylyl cyclase activity in Q227L., and control membranes. Membraneswere assayedfor adenylyl cyclaseactivity asdescribedin Materials Values represent the means of at least
and Methods.
duplicate
determinations (n = 2 - 6). Effector concentrations were as follows: 100 FM GTP; 3 PM PGEl; 100PM Gpp(NH)p; 100W forskolin.
the presence of E-type prostaglandins, stimulate
DNA synthesis in Swiss 3T3 cells (21, adenylyl
considerably
higher
or uninfected catalytic
(275%) than in membranes
cells.
subunit
The diterpene
of adenylyl
agents as a stimulator activity
Although
hydrolysis-resistant activity
which
cyclase, though
forskolin
acts directly
effect
GTP-analogue
either GTP or GTP plus PGEl.
acts directly
on the
than other
again forskolin-stimulated with GRS or uninfected
on the catalytic
subunit
of
are in accordance with evidence (22, 23) that
the stimulatory
in Q227L membranes,
was
from GRS-infected
more effective
greater in Q227L,, compared
cyclase, these findings
as potentiates
forskolin,
CAMP and
cyclase activity
prepared
cyclase, was much
of adenylyl
was significantly
membranes. adenylyl
which increase intracellular
relative
of this
Gpp(NH)p to activity
Surprisingly,
reduced
adenylyl
measured
This result parallels 1187
agent.
the cyclase
in the presence of
the effect of Gpp(NH)p
in
BIOCHEMICAL
Vol. 166, No. 3, 1990
S49 cell membranes activation
expressing
AND BIOPHYSICAL
the Q227L
RESEARCH COMMUNICATIONS
as protein
and may reflect
of Gi by this agent (7,B). RNA extracted from wild-type,
cells contained Northern
only a single major 01~ transcript
hybridization
with a full-length
uninfected
of -2000 bp as detected by
probe for mouse as. In contrast,
RNA isolated from Q227L and GRS-infected
cells contained,
endogenous
species of -6100 bp (results not
shown).
as transcript,
a larger mRNA
The length of this message corresponds
for an LTR to LTR transcript cDNA (18). Immunoblot significant
alteration
either mutant recombinant constitutes
analysis with anti-as
or wild-type
the predominant
observations).
the as
did not reveal any associated
Presumably
by the endogenous
with
expression
52 kDa protein
of
which
form of 01~in these cells (I. Zachary, unpublished observed in 42272. Swiss 3T3 cells is not
Table
CUP
antiserum
of the 52 kDa as protein
Thus, the phenotype
Intracellular
vector containing
as (results not shown).
c+ is masked
to the
closely to the size predicted
from the retroviral
in expression
in addition
accumulation
in
1
Sviss CARP
3T3
cells
(pmoles/mg
expressing
Q227L
or-
protein)
Addition
VT
GRS 5
None
2.6
2.7
IBBX
a.3
9.2
117.8
51.4
4.2
3.2
38
33
4.3
3.5
aa
78
Ro
20-1724
PGEl
PGEl
+ Ro
20-1724
Forskolin
214
360
Forskolin + Ro 20-1724
576
727
tluiescent absence (100
ukl);
solvent. (i.e.
cultures
or
presence PGEl Values
with
(250
the
rig/ml);
represent
performed cells
cells
were
following forskolin the
no additions)
Experiments Q227L-12
of of
represent with
GRS-7
of the
in
DHEH the
and
0227L-10
and
ufl).
All
least
duplicate
of
incubated
3.5
156
300
722
800
cultures
cells
produced
1188
the
same
indicated: were
treated
determinations
10 determinations
respectively.
1,700
in
concentrations
results
medium
for
IBBX
(500
the
same
vith (n
obtained similar
12
6.5
1,400
at
mean
Q227L
2.7
washed
at
pool
7.5
agents (50
mean
Q227L
= 2 - 8);
from
1 hr ukl); volume
basal
5 different to
those
in
the
Ro 20-1724 of CARP
levels
experiments. shown
for
GRS-5
and
BIOCHEMICAL
Vol. 168, No. 3, 1990
due to an increased
AND BIOPHYSICAL
total level of the 52 kDa protein
consequence of expression of the mutant Treatment
of intact, quiescent
of CAMP phosphodiesterase
increases
in intracellular
CAMP
intracellular
(IBMX
1).
Cells
expressing
cells exhibited
much
smaller
and PGEl
normal,
increases in
Ro 20-1724 potentiated
on intracellular
cAMP in all the cells
but the increases in CAMP were greater in the Q227L cells compared
to either GRS or uninfected
cells. Basal, unstimulated
modestly
elevated
but significantly
The much presence
more dramatic
adenylyl
in Q227L cells relative
activity
inhibitors
probably
in Q227L cells.
indicates
in the
increased between the
the same mutant
that the Q227L mutation
as cDNA
causes constitutive
of a, as a direct consequence of reduced GTPase activity (10, 11,131.
Insulin,
which has no effect on intracellular
(21, was weakly mitogenic
insulin-induced
DNA
synthesis
response to insulin
20-1724 were as effective combinations
of insulin
in uninfected
in cells expressing
in reinitiating
DNA
synthesis
with either cholera toxin or PGEl. A significant
Similarly,
incorporation
concentration
Forskolin
In marked
and Ro
in Q227L
cells as
The effect of Ro
increase in 3H-thymidine as low as 1 uM
and GRS cells with
of -25 PM and a maximal
the
Insulin
in the presence of insulin
in uninfected
1189
increase in
potentiated
Q227L a,.
in Q227L cells was observed at a concentration
(results not shown). 3H-thymidine
and GRS cells.
of Ro 20-1724 strikingly
20-1724 was concentration-dependent: incorporation
(Fig. 2). Ro 20-
of 100 PM, caused only a small further
the same concentration
mitogenic
CAMP levels in these cells
by itself in all the cells examined
1724, at a concentration
contrast,
cells.
in Q227L Swiss 3T3 cells and
(10) in S49 cyc- (24) cells expressing
(10) is consistent with the finding activation
to control
The close similarity
cyclase activity and CAMP accumulation
that reported
CAMP content was also
increase in CAMP of Q227L cells observed
of phosphodiesterase
phosphodiesterase
maximal
or
or Ro 20-1724) caused striking
CAMP in response to the same agents.
the effects of both forskolin studied,
form of 01~.
(Table
as and uninfected
but is rather a specific
cultures of Q227L cells with forskolin
inhibitors
recombinant
RESEARCH COMMUNICATIONS
increased a half-
response at 100 PM (Fig. 3,
Vol.
168, No. 3, 1990
BIOCHEMICAL
AND BIOPHYSKAL
50
25
RESEARCH COMMUNICATIONS
GRS5
25 -
.C
:
*
5o -
0227
50-
Pool
Q227L
12
e ,I
25 -
Ram- -r
-1724
o-
-
Fig. 2: Effect of CAMP-elevating agentson 3H-thymidine incorporation
in Swiss 3T3 cells expressing Q227L a,. Cells were incubated for 40 hr with 3H-thymidine either in the presenceor absenceof 100 PM Ro 20-1724and in the presenceof either an equal volume of solvent, 100 rig/ml cholera toxin, or 250rig/ml PGEl. All cultures except thosereceiving no additions were also treated with 1 pg/ml insulin. The values shown represent the means of at least 4 determinations (n = 4 - 81 and are expressed as percentages of the response obtained in the presence of 10% FCS. Duplicate determinations agreed within 10%. Results similar to those for GRS-5 and Q227L 12 were obtained using respectively GRS7 and Q227L 10cells.
upper panel and results not shown).
In contrast, forskolin stimulated DNA
synthesis in Q227L cells at concentrations as low as 0.1 PM and maximally between 0.6 and 2 yM.
Enhanced mitogenic responsiveness of Q227L Swiss 1190
Vol. 168, No. 3, 1990
BIOCHEMICAL
300. C I e a 0) 200. E
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
WT
GM
d
d
w-f
GRS 5
5
5 E a loo oz 3 3
II
0-
0
100
n 0
1
100
d 0
1
dl
1
0
0.6
Forskolin,
(rhl
1
0.6
Fig. 3: Effect of forskolin on DNA synthesis (upper) and CAMP accumulation (lower) in Swiss 3T3 cells expressing recombinant as. Quiescent cultures of wild-type uninfected (WT), GRS 5, Q227L pool or Q227L, 12 Swiss 3T3 cells were incubated with different concentrations of forskolin either in the presenceor absenceof insulin at 1 &ml.
Measurements of
intracellular CAMP (lower) were made 1 hr after addition of forskolin.
Each
value represents the mean of either 4 (upper) or 2 (lower) determinations which agreed within 5-10%. Values for 3H-thymidine
incorporation are
expressedas in Fig.2. Experiments performed with GRS-7 and Q227L-10cells produced similar results to those shown for GRS-5 and Q227L 12 cells respectively.
3T3 cells to forskolin intracellular
CAMP.
was closely paralleled
Thus, in quiescent Q227L cells, forskolin
increase in CAMP content which maximally (Fig. 3, upper markedly DNA
at concentrations
stimulated panel).
3H-thymidine
in control
cells.
incorporation
production
in parallel range,
cultures
forskolin
of intracellular
These results indicate 1191
caused a large
(0.6-l PM) (Fig. 3, lower panel)
In the same concentration
less effective in stimulating
synthesis
by the effect of this agent on
was
CAMP and
that enhanced
Vol.
BIOCHEMICAL
168, No. 3, 1990
mitogenic
responsiveness
AND BIOPHYSICAL RESEARCH COMMUNlCATlONS
of the Q227L cells is probably
a direct consequence
of enhanced CAMP synthesis. Recent findings consequence glutamine tumours
of activating
(13, 25, 26).
production
in c+, including
to the abnormal
growth
Thus it has been proposed
consistent
the phenotype
cyclase activity
sufficiently
to trigger
carcinogenesis
mitogenesis,
cyclase.
In conclusion,
transformation will require
to exhibit
different mitogenic
cell growth
inhibiting
designated the mutant
we predict with
alterations
signaling
a, is
CAMP Just as
mutation,
Swiss
in this case a phosphodiesterase
effect of constitutively that aberrant
mutations
gsp
(2), the increased
more than one oncogenic
the mitogenic
associated concomitant
of
even in the presence of insulin.
3T3 cells appear to require a “second hit” -
replacement
caused by Q227L as does not elevate cellular
appears to require
inhibitor
as a
that GTPase
of Swiss 3T3 cells expressing
with a role for CAMP in signalling
of CAMP
of certain pituitary
in the 01s gene convert it into a novel oncogene,
While
adenylyl
mutations
227, may contribute
mutations (13).
suggest that constitutive
cell growth
that trigger
active adenylyl and malignant
generation
in either the CAMP signaling
of CAMP system, a
pathway, or both.
REFERENCES 1. Dumont, J.E., Jauniaux, J-C. and Roger, PP. (1989). Trends Biochem. Sci., 14,67-71. 2. Rozengurt, E. (1986). Science, 234,161-166. 3. Rozengurt, E., Stroobant, P., Waterfield, M.D., Deuel. T.F. and Keehan, M. (1983). Cell, 34,265-272. 4. Zurier, R.B., Kozma, M., Sinnett-Smith, J. and Rozengurt, E. (1988). Exp. Cell Res., 176,155-161. J.B.A. and Rozengurt, E. (1988). J. Cell. Physiol. 137,214222. 5. Milk, 6. Rozengurt, E., Murray, M., Zachary, I. and Collins, M. (1987). Proc. Natl. Acad. Sci. U.S.A., 84,2282-2286. 7. Stryer, L. and Boume, H.R. (1986). Ann. Rev. Cell Biol., 2, 391-419. 8. Gilman, A.G. (1987). Ann. Rev. Biochem. 56,6X%649. 9. Boume, H.R., Masters, S.B., Miller, RT., Sullivan, K.A. and Heideman, W. (1988). Cold Spring Harbour Symp. Quark Biol. 53,221~228. 10. Masters, S.B., Miller, R.T., Ming-Hui, C., Chang, F-H., Beiderman, B., Lopez, N.G. and Boume, H.R. (1989). J. Biol. Chem., 264,15467-15474. II. Graziano, M.P. and Gilman, A.G. (1989). J.Biol. Chern., 264, 15475-15482. 12. Barbacid, M. (1987). Ann. Rev. Biochem., 56, 779-827. 1192
Vol. 168, No. 3, 1990
BIOCHEMICAL
AND RIOPHYSICAL RESEARCH COMMUNICATIONS
13. Landis, C.A., Masters, S.B., Spada, A., Pace, A.M., Bourne, H.R. and Vallar, L. (1989). Nature, 340,692-696. 14. Dicker, P. and Rozengurt, E. (1980). Nature, 287,607-612. 15. SaIomon, Y., Londos, C. and Rodbell, M. (1974). Anal. Biochem., 58, 541548. 16. Perkins, J.P. and Moore, M.M. (1973). J. Pharmacol. Exp. Ther., 185,371378. 17. Jones, D.T. and Reed, R.R. (1987). J. Biol. Chem., 262, 14241-14249. 18. Kirschmeier, P.T., Housey, G.M., Johnson, M.D., Perkins, AS. and Weinstein, LB. (1988). DNA, 7, 219-225. 19. Sullivan, K.A., Miller, R.T., Masters, S.B., Beiderman, B., Heideman, W. and Bourne, H.R (1987). Nature, 330,758-760. 20. Lowry, O.H., Rosebrough, N.S., Farr, A.L. and Randall, R.J. (1951). J. Biol. Chem. 253,7120-7123. 21. Masters, S.B., Sullivan, K.A., Miller, R.T., Beiderman, B., Lopez, N.G., Ramachandran, J. and Bourne, H.R. (1988). Science, 241,448-451. 22. Green, D.A. and Clark, R.B. (1982). J. Cyclic Nucl. Res. 8,336-346. 23. Bender, J.L. and Neer, E.J. (1983). J. Biol. Chem. 258,2432-2439. 24. Insel, P.A., Bourne, H.R., Coffino, P. and Tomkins, G.M. (1975). Science, 190,896-898. 25. Vallar, L., Spada, A. and Giannattasio, G. (1987). Nature, 330,566-568. 26. Billestrup, N., Swanson, L.W. and Vale, W. (1986). Proc. Natl. Acad. Sci. U. S. A., 83,6854-6857.
1193